Free circulating mRNA in plasma from breast cancer patients and clinical outcome

Cancer Letters

Volumn 263, Issue 2, 2008, Pages 312-320

  García, Vanesa ^a   García, José M ^a   Peña, Cristina ^a   Silva, Javier ^a   Domínguez, Gemma ^a   Lorenzo, Yolanda ^a   Diaz, Raquel ^a   Espinosa, Pablo ^a   de Sola, Javier García ^a   Cantos, Blanca ^a   Bonilla, Félix ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Breast cancer; Cyclin D1; mRNA; Plasma; Prognostic; TS

Indexed keywords

CYCLIN D1; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; MESSENGER RNA; METHOTREXATE; TAMOXIFEN; THYMIDYLATE SYNTHASE;

ARTICLE; BLOOD LEVEL; BREAST CANCER; CANCER RELAPSE; DISEASE FREE SURVIVAL; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT RESPONSE;

BREAST NEOPLASMS; CYCLIN D1; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; PROGNOSIS; PROSPECTIVE STUDIES; RNA, MESSENGER; SURVIVAL ANALYSIS; TAMOXIFEN; THYMIDYLATE SYNTHASE; TREATMENT OUTCOME;

EID: 41649115577     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.01.008     Document Type: Article

References (29)

1. Leon S.A., Shapiro B., Sklaroff D.M., and Yaros M.J. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res. 37 (1976) 646-650
2. Shapiro B., Chakrabarty M., Cohn E.M., and Leon S.A. Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease. Cancer 51 (1983) 2116-2120
3. Garcia J.M., Garcia V., Silva J., Pena C., Dominguez G., Sanchez A., Sanfrutos L., Provencio M., Millan I., Chaparro D., Espana P., and Bonilla F. Extracellular tumor DNA in plasma and overall survival in breast cancer patients. Genes Chromosome Cancer 45 (2006) 692-701
4. Silva J.M., Dominguez G., Silva J., Garcia J.M., Sanchez A., Rodriguez O., Provencio M., Espana P., and Bonilla F. Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics. Clin. Cancer Res. 7 (2001) 2821-2825
5. Dasi F., Lledo S., Garcia-Granero E., Ripoll R., Marugan M., Tormo M., Garcia- Conde J., and Alino S.F. Real-time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA: a simple blood test to monitor disease in cancer patients. Lab. Invest. 81 (2001) 767-769
6. Silva J.M., Rodriguez R., Garcia J.M., Munoz C., Silva J., Dominguez G., Provencio M., Espana P., and Bonilla F. Detection of epithelial tumor RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells. Gut 50 (2002) 530-534
7. Wong S.C., Lo S.F., Cheung M.T., Ng K.O., Tse C.W., Lai B.S., Lee K.C., and Lo Y.M. Quantification of plasma beta-catenin mRNA in colorectal cancer and adenoma patients. Clin. Cancer Res. 10 (2004) 1613-1617
8. Fu M., Wang C., Li Z., Sakamaki T., and Pestell R.G. Minireview: cyclin D1: normal and abnormal functions. Endocrinology 145 (2004) 5439-5447
9. Hinds P.W., Dowdy S.F., Eaton E.N., Arnold A., and Weinberg R.A. Function of a human cyclin gene as an oncogene. Proc. Natl. Acad. Sci. USA 91 (1994) 709-713
10. Wang T.C., Cardiff R.D., Zukerberg L., Lees E., Arnold A., and Schmidt E.V. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369 (1994) 669-671
11. Lovec H., Grzeschiczek A., Kowalski M.B., and Moroy T. Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J. 13 (1994) 3487-3495
12. Popat S., Matakidou A., and Houlston R.S. Thymidylate synthase expression and prognosis in colorectal caner: a systematic review and meta-analysis. J. Clin. Oncol. 22 (2004) 529-536
13. Shirota Y., Stoehlmacher J., Brabender J., Xiong Y.P., Uetake H., Danenberg K.D., Groshen S., Tsao-Wei D.D., Danenberg P.V., and Lenz H.J. ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy. J. Clin. Oncol. 19 (2001) 4298-4304
14. Santi D.V., McHenry C.S., and Sommer H. Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate. Biochemistry 13 (1974) 471-481
15. Rustum Y.M., Harstrick A., Cao S., Vanhoefer U., Yin M.B., Wilke H., and Seeber S. Thymidylate synthase inhibitors in cancer therapy: direct and indirect inhibitors. J. Clin. Oncol. 15 (1997) 389-400
16. Allegra C.J. Antifolates: the next millennium. Semin. Oncol. 26 (1999) 1-2 (S6)
17. Edler D., Glimelius M., Hallstrom M., Jakobsen A., Johnston P.G., Magnusson I., Ragnhammar P., and Blomgren H. Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil based chemotherapy. J. Clin. Oncol. 20 (2002) 1721-1728
18. Johnston P.G., Lenz H.J., Leichman C.G., Danenberg K.D., Allegra C.J., Danenberg P.V., and Leichman L. Thymidilate synthase gene and protein expression correlate and are associated with a response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res. 55 (1995) 1407-1412
19. Kakimoto M., Uetake H., Osanai T., Shirota Y., Takagi Y., Takeshita E., Toriya Y., Danenberg K., Danenberg P.V., and Sugihara K. Thymidylate synthase and dihydropyrimidine dehydrogenase gene expression in breast cancer predicts 5-FU sensitivity by a histocultural drug sensitivity test. Cancer Lett. 223 (2005) 103-111
20. Hakamada Y., Tsuchida A., Arima M., Kubouchi T., Tokita H., Ota D., Kaise H., Aoki T., Kusama M., and Aoki T. Prognostic predictors in breast cancer patients with postoperative 5-fluorouracil-based chemotherapy. Int. J. Mol. Med. 16 (2005) 309-314
21. Pestalozzi B.C., Peterson H.F., Gelber R.D., Goldhirsch A., Gusterson B.A., Trihia H., Lindtner J., Cortes-Funes H., Simmoncini E., Byrne M.J., Golouh R., Rudenstam C.M., Castiglione-Gertsch M., Allegra C.J., and Johnston P.G. Prognostic importance of thymidylate synthase expression in early breast cancer. J. Clin. Oncol. 15 (1997) 1923-1931
22. Foekens J.A., Romain S., Look M.P., Martin P.M., and Klijn J.G.M. Thymidine kinase and thymidylate synthase in advanced breast cancer: response to tamoxifen and chemotherapy. Cancer Res. 61 (2001) 1421-1425
23. Allegra C.J., Paik S., Colangelo L.H., Parr A.L., Kirsch I., Kim G., Klein P., Johnston P.G., Wolmark N., and Wieand H.S. Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study. J. Clin. Oncol. 21 (2003) 241-250
24. Allegra C.J., Parr A.L., Wold L.E., Mahoney M.R., Sargent D.J., Johnston P., Klein P., Behan K., O'Connell M.J., Levitt R., Kugler J.W., Tria Tirona M., and Goldberg R.M. Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer. J. Clin. Oncol. 20 (2002) 1735-1743
25. Garcia V., Garcia J.M., Pena C., Silva J., Dominguez G., Hurtado A., Alonso I., Rodriguez R., Provencio M., and Bonilla F. Thymidylate synthase messenger RNA expression in plasma from patients with colon cancer: prognostic potential. Clin. Cancer Res. 12 (2006) 2095-2100
26. Garcia J.M., Silva J.M., Dominguez G., Silva J., and Bonilla F. Heterogeneous tumor clones as an explanation of discordance between plasma DNA and tumor DNA alterations. Genes Chromosome Cancer 31 (2001) 300-301
27. Silva J., Silva J.M., Garcia V., Garcia J.M., Dominguez G., and Bonilla F. RNA is more sensitive than DNA in identification of breast cancer patients bearing tumor nucleic acids in plasma. Genes Chromosome Cancer 35 (2002) 375-376
28. Butt A.J., McNeil C.M., Musgrove E.A., and Sutherland R.L. Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E. Endocr. Relat. Cancer 12 (2005) S47-S59
29. Kenny F.S., Hui R., Musgrove E.A., Gee J.M., Blamey R.W., Nicholson R.I., Sutherland R.L., and Robertson J.F. Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer. Clin. Cancer Res. 5 (1999) 2069-2076